ORBIMED ADVISORS LLC

Position in VERA — Vera Therapeutics, Inc.

CIK 1055951 New York, NY

Position in VERA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$15,859,364

+$990,517 QoQ

Shares Held

369,596

0.0% QoQ

Ownership

0.513%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

#40

of 217 holders

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 50% Shared 0% None 50%

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. VERA ranks #49 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EWTX	Edgewise Therapeutics, Inc.	15,518,492	$630,516,329
2	ELVN	Enliven Therapeutics, Inc.	6,776,632	$343,914,074
3	MBX	MBX Biosciences, Inc.	3,428,736	$189,266,227
4	GPCR	Structure Therapeutics Inc.	2,209,400	$118,578,498
5	SION	Sionna Therapeutics, Inc.	2,555,877	$112,433,029
6	CRVS	Corvus Pharmaceuticals, Inc.	7,165,006	$107,045,189
7	AVBP	ArriVent BioPharma, Inc.	3,027,328	$105,169,374
8	ARGX	Argenx SE	92,880	$86,171,277

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,859,364	369,596	0.0%	Shares	Defined	2026-08-14
2026-03-31	$14,868,847	369,596	+4.6%	Shares	Defined	2026-05-15
2025-12-31	$17,901,240	353,500	-26.5%	Shares	Defined	2026-02-17
2025-03-31	$11,555,181	481,065	-35.2%	Shares	Defined	2025-05-15
2024-12-31	$31,403,369	742,572	+9.9%	Shares	Defined	2025-02-14
2024-09-30	$29,873,542	675,872	0.0%	Shares	Defined	2024-11-14
2024-06-30	$24,453,048	675,872	0.0%	Shares	Defined	2024-08-14
2024-03-31	$29,143,600	675,872	-55.5%	Shares	Defined	2024-05-15
2023-12-31	$23,348,608	1,518,115	0.0%	Shares	Defined	2024-02-14
2023-09-30	$20,813,356	1,518,115	-13.6%	Shares	Defined	2023-11-14
2023-06-30	$28,196,640	1,756,800	+28.9%	Shares	Defined	2023-08-14
2023-03-31	$10,572,224	1,362,400	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.